WHAT DISEASES CAN BE TREATED WITH STEM CELLS?

WHAT DISEASES CAN BE TREATED WITH STEM CELLS?

Little by little, technology and scientific advances are breaking down the limitations of modern medicine. Today there are alternative treatments with high rates of effectiveness for diseases that were previously considered a death sentence.

We owe part of this significant advance to stem cells, the body’s raw material that gives life to other cells with specialized functions, such as heart, brain, bone, etc. That is, cells capable of replacing cells affected by a disease.

Although there are many chronic diseases and other conditions treated with stem cells, today we present 3 of them that stand out among the others for their significant advances in recent years xnxx.

what are stem cells?

Stem cells: What they are and what they do

DIABETES

DIABETES

Today, diabetes is no stranger to anyone. Whether you yourself or someone close to you suffers from it, surely you have been able to see its effects on your health: living with daily insulin injections and keeping a strict control to avoid permanent damage to the human body as much as possible.

Although the specific causes that cause its appearance are certainly not known, the possibility of using stem cells to destroy and replace the cells that cause type 1 diabetes is currently being studied.

At the moment, research continues at the level of clinical trials with species of devices to protect the immune system of patients. However, there are also other studies trying to prove using stem cells to promote the reproduction of healthy pancreatic cells in a natural way.

MYOCARDIAL INFARCTIONS

MYOCARDIAL INFARCTIONS

Many call him “The Silent Killer”. A fear with which one lives constantly, knowing how statistically possible its appearance is in any patient. Not surprisingly, at least 7 million heart attacks are recorded each year, in addition to being the leading cause of death in Europe.

As with diabetes, little is known specifically about heart attacks. The generation of new cardiomyocytes remains a mystery to medicine. However, the possibility of using stem cells to regenerate a heart affected by myocardial infarction is being studied.

However, at the moment, it remains somewhat tested on animals.

LEUKEMIA

LEUKEMIA

Not surprisingly, patients with advanced leukemia have been the first to experiment with stem cells. Especially, understanding that this disease is born from mutations in the systems linked to the creation of blood tissues.
One of the approaches that has received the most attention in the world of medicine is the one that seeks to use stem cells to create healthy autoimmune cells.

MULTIPLE SCLEROSIS

MULTIPLE SCLEROSIS

Perhaps this is, just after cancer in any of its forms, one of the cruelest and most common diseases at the same time. Multiple sclerosis is silent, painful and, at least for now, very difficult to stop.

For this reason, scientific researchers seek to use stem cells to intervene positively in the repair of myelin damage to cells.

Some approaches involve using chemotherapy to destroy the patient’s current immune system and then using stem cells to restore it. However, it is still an extremely high and risky bet.

On the other hand, the possibility of using stem cells to repair nerves affected by sclerosis is also being studied.
With the growing technological advances that continue to revolutionize the world of medicine, what other diseases do you think can be cured with stem cells?

 

 

Related Posts

EMBRYONIC STEM CELLS: Does it all start here? What does the patent landscape look like?

The Potential is Real – The Confusion is Overwhelming – The Passion is Blinding.  So What do we do? Is sticking our heads in the sand of ignorance the right approach?

We wanted to explore what is going on in the intellectual property front of the embryonic stem cell landscape.  This will provide insight into what the research and business enterprises focus in.  it will shed light on directions, possibilities, and actualities.

Note though, that not all that’s patented is all that there is … for example the Geron Corporation is associated with only the following patents associated directly with embryonic stem cells.
Clearly, from title analysis, Mammalian Telomerase is a one of their major keys to the lock.
PAT. NO.  Title 
1 6,258,535  Mammalian telomerase  
2 6,166,178  Telomerase catalytic subunit  
3 6,147,276  Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos  
4 6,054,575  Mammalian telomerase RNA gene promoter  
5 5,958,680  Mammalian telomerase  
6 5,837,857  Mammalian telomerase  
7 5,776,679  Assays for the DNA component of human telomerase  
8 5,583,016  Mammalian telomerase
LISTING OF THE MOST CURRENT U.S. PATENTS on EMBRYONIC STEM CELLS
PATENT #  Title 
6,274,363  Phosphatidylcholine phospholipase D  
6,274,362  RGS-containing molecules and uses thereof  
6,274,338  Human c-Maf compositions and methods of use thereof  
6,274,309  Method for the modulation of acid-sphingomyelinase-related apoptosis  
6,271,436  Cells and methods for the generation of transgenic pigs  
6,271,348  Tetracycline-inducible transcriptional inhibitor fusion proteins  
6,271,341  Transcriptional activators with graded transactivation potential  
6,270,778  Melanoma antigens and their use in diagnostic and therapeutic methods  
6,268,135  Phospholipase molecule and uses therefor  
6,268,130  RP compositions and diagnostic uses therefor  
6,265,564  Expressed ligand-vascular intercellular signalling molecule  
6,265,546  Prostate cancer gene  
6,262,337  Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof  
6,262,235  Leptospiral outer membranes protein, LipL46  
6,262,035  Gene replacement therapy for muscular dystrophy  
6,261,818  CARK protein and nucleic acid molecules and uses therefor  
6,258,998  Method of cloning porcine animals  
6,258,582  CSAPTP nucleic acid molecules and uses therefor  
6,258,557  Smooth muscle cell LIM promoter  
6,258,535  Mammalian telomerase  
6,255,473  Presenilin-1 gene promoter  
6,255,458  High affinity human antibodies and human antibodies against digoxin  
6,255,112  Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells  
6,252,136  Transgenic organisms having tetracycline-regulated transcriptional regulatory systems  
6,252,132  Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor  
6,252,051  ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor  
6,251,671  Compositions and methods of making embryonic stem cells  
6,248,934  Gene trap vectors  
6,248,527  Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E  
6,245,969  Receptor kinase, Bin1  
6,245,566  Human embryonic germ cell line and methods of use  
6,245,529  Testis-specific cystatin-like protein cystatin T  
6,245,527  Nucleic acid molecules encoding glycoprotein VI and recombinant uses thereof  
6,242,667  Transgenic organisms having tetracycline-regulated transcriptional regulatory porno mexicano systems  
6,242,588  Testis specific glycoprotein zpep10  
6 6,242,236  Method of promoting enzyme diversity  
6,239,326  Sparc-deficient transgenic mice  
6,238,903  SH2-containing inositol-phosphatase  
6,238,881  Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase